ciclesonide HFA 160 μg
Sponsors
Sumitomo Pharma America, Inc.
Conditions
Perennial Allergic RhinitisSeasonal Allergic Rhinitis
Phase 3
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older
CompletedNCT01010971
Start: 2009-12-31End: 2010-02-28Updated: 2012-06-13
A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
CompletedNCT01067105
Start: 2010-02-28End: 2010-11-30Updated: 2012-06-13